Evaluation of quantification of hiv-1 RNA viral load in plasma and dried blood spots by use of the semiautomated cobas amplicor assay and the fully automated cobas ampliprep/taqman assay, version 2.0, in Kisumu, Kenya

Journal of Clinical Microbiology

Volumn 51, Issue 4, 2013, Pages 1208-1218

  Ouma, Kenneth N ^a   Basavaraju, Sridhar V ^b   Okonji, Jully A ^a   Williamson, John ^c   Thomas, Timothy K ^c   Mills, Lisa A ^c   Nkengasong, John N ^b   Zeh, Clement ^c  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DRIED BLOOD SPOT TESTING; FEMALE; FULLY AUTOMATED COBAS AMPLIPREP TAQMAN ASSAY; GENE AMPLIFICATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; KENYA; LIMIT OF DETECTION; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEMIAUTOMATED COBAS AMPLICOR ASSAY; SENSITIVITY AND SPECIFICITY; VIRUS CULTURE; VIRUS DETECTION; VIRUS LOAD;

AUTOMATION, LABORATORY; BLOOD; DESICCATION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KENYA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEOPOLYHEDROVIRUS;

EID: 84875860293     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03048-12     Document Type: Article

References (41)

1. UNAIDS. 2010. UNAIDS report on the global AIDS epidemic 2010. UNAIDS, Geneva, Switzerland. www.unaids.org/globalreport/global-report.htm. Accessed 23 May 2011.
2. WHO. 2010. Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. 2010 revision. WHO, Geneva, Switzerland. whqlibdoc.who.int/publications/2010/9789241599764-eng.pdf. Accessed 10 June 2011.
3. Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankale JL, Dieng-Sarr A, Agbaji O, Onwujekwe DI, Gashau W, Nkado R, Ekong E, Okonkwo P, Murphy RL, Kanki PJ. 2011. Immunologic criteria are poor predictors of virologic outcome: Implications for HIV treatment monitoring in resource-limited settings. Clin. Infect. Dis. 53:1283-1290.
4. van Oosterhout JJ, Brown L, Weigel R, Kumwenda JJ, Mzinganjira D, Saukila N, Mhango B, Hartung T, Phiri S, Hosseinipour MC. 2009. Diagnosis of antiretroviral therapy failure in Malawi: Poor performance of clinical and immunological WHO criteria. Trop. Med. Int. Health 14: 856-861.
5. Anema A, Lima VD, Johnston K, Levy A, Montaner JS. 2009. Expanded highly active antiretroviral therapy coverage-a powerful strategy to curb progression to AIDS, death and new Infections. Eur. Infect. Dis. 3:41-43.
6. Isaakidis P, Raguenaud ME, Te V, Tray CS, Akao K, Kumar V, Ngin S, Nerrienet E, Zachariah R. 2010. High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia. J. Int. AIDS Soc. 13:11. doi:10.1186/1758-2652-13-11.
7. Rouet F, Ekouevi DK, Chaix ML, Burgard M, Inwoley A, Tony TD, Danel C, Anglaret X, Leroy V, Msellati P, Dabis F, Rouzioux C. 2005. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J. Clin. Microbiol. 43:2709-2717.
8. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR. 2011. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 365:493-505.
9. FDA. 2011. Complete list of donor screening assays for infectious agents and HIV diagnostic assays. FDA, Rockville, MD. http://www.fda.gov/ biologicsbloodvaccines/bloodbloodproducts/approvedproducts/licensedproductsblas/ blooddonorscreening/infectiousdisease/ucm080466.htm. Accessed 5 June 2011.
10. Johannessen A. 2010. Dried blood spots in HIV monitoring: Applications in resource-limited settings. Bioanalysis 2:1893-1908.
11. Nsubuga FM, Jaakkola MS. 2005. Needle stick injuries among nurses in sub-Saharan Africa. Trop. Med. Int. Health 10:773-781.
12. Sadoh WE, Fawole AO, Sadoh AE, Oladimeji AO, Sotiloye OS. 2006. Practice of universal precautions among healthcare workers. J. Natl. Med. Assoc. 98:722-726.
13. Taegtmeyer M, Suckling RM, Nguku PM, Meredith C, Kibaru J, Chakaya JM, Muchela H, Gilks CF. 2008. Working with risk: Occupational safety issues among healthcare workers in Kenya. AIDS Care 20:304-310.
14. Yang C, McNulty A, Diallo K, Zhang J, Titanji B, Kassim S, Wadonda-Kabondo N, Aberle-Grasse J, Kibuka T, Ndumbe PM, Vedapuri S, Zhou Z, Chilima B, Nkengasong JN. 2010. Development and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of HIV-1 drug resistance. J. Clin. Microbiol. 48:3158-3164.
15. Murphy DG, Cote L, Fauvel M, Rene P, Vincelette J. 2000. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 38:4034-4041.
16. Katsoulidou A, Petrodaskalaki M, Sypsa V, Papachristou E, Anastassopoulou CG, Gargalianos P, Karafoulidou A, Lazanas M, Kordossis T, Andoniadou A, Hatzakis A. 2006. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays-LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) andCOBASAMPLICORHIV-1 Monitor v1.5. J. Virol. Methods 131:168-174.
17. Leelawiwat W, Young NL, Chaowanachan T, Ou CY, Culnane M, Vanprapa N, Waranawat N, Wasinrapee P, Mock PA, Tappero J, McNicholl JM. 2009. Dried blood spots for the diagnosis and quantitation of HIV-1: Stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand. J. Virol. Methods 155:109-117.
18. Uttayamakul S, Likanonsakul S, Sunthornkachit R, Kuntiranont K, Louisirirotchanakul S, Chaovavanich A, Thiamchai V, Tanprasertsuk S, Sutthent R. 2005. Usage of dried blood spots for molecular diagnosis and monitoring HIV-1 infection. J. Virol. Methods 128:128-134.
19. Schumacher W, Frick E, Kauselmann M, Maier-Hoyle V, van der Vliet R, Babiel R. 2007. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS Ampli-Prep/COBAS TaqMan system. J. Clin. Virol. 38:304-312.
20. Pas S, Rossen JW, Schoener D, Thamke D, Pettersson A, Babiel R, Schutten M. 2010. Performance evaluation of the new Roche Cobas AmpliPrep/ Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA. J. Clin. Microbiol. 48:1195-1200.
21. Amendola A, Coen S, Belladonna S, Pulvirenti FR, Clemens JM, Capobianchi MR. 2011. Improving clinical laboratory efficiency: A timemotion evaluation of the Abbott m2000 RealTime and Roche COBAS AmpliPrep/COBAS TaqMan PCR systems for the simultaneous quantitation of HIV-1 RNA andHCVRNA. Clin. Chem. Lab. Med. 49:1283-1288.
22. Andreotti M, Pirillo M, Guidotti G, Ceffa S, Paturzo G, Germano P, Luhanga R, Chimwaza D, Mancini MG, Marazzi MC, Vella S, Palombi L, Giuliano M. 2010. Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay. J. Clin. Virol. 47:4-7.
23. Stevens W, Erasmus L, Moloi M, Taleng T, Sarang S. 2008. Performance of a novel human immunodeficiency virus (HIV) type 1 total nucleic acid-based real-time PCR assay using whole blood and dried blood spots for diagnosis of HIV in infants. J. Clin. Microbiol. 46:3941-3945.
24. WHO. 1 June 2010, posting date. Technical brief on HIV viral load technologies (June 2010). WHO, Geneva, Switzerland. www.who.int/hiv/topics/ treatment/tech-brief-20100601-en.pdf.
25. Mirochnick M, Thomas T, Capparelli E, Zeh C, Holland D, Masaba R, Odhiambo P, Fowler MG, Weidle PJ, Thigpen MC. 2009. Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy. Antimicrob. Agents Chemother. 53:1170-1176.
26. Thomas TK, Masaba R, Borkowf CB, Ndivo R, Zeh C, Misore A, Otieno J, Jamieson D, Thigpen MC, Bulterys M, Slutsker L, De Cock KM, Amornkul PN, Greenberg AE, Fowler MG. 2011. Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding-the Kisumu Breastfeeding Study, Kenya: A clinical trial. PLoS Med. 8:e1001015. doi:10.1371/journal.pmed. 1001015.
27. Zeh C, Weidle PJ, Nafisa L, Lwamba HM, Okonji J, Anyango E, Bondo P, Masaba R, Fowler MG, Nkengasong JN, Thigpen MC, Thomas T. 2011. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: A secondary analysis. PLoS Med. 8:e1000430. doi:10.1371/journal.pmed.1000430.
28. Reigadas S, Schrive MH, Aurillac-Lavignolleb V, Fleury HJ. 2009. Quantitation of HIV-1 RNA in dried blood and plasma spots. J. Virol. Methods 161:177-180.
29. Pyne MT, Brown KL, Hillyard DR. 2010. Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance. J. Clin. Microbiol. 48: 2852-2858.
30. Fiscus SA, Brambilla D, Grosso L, Schock J, Cronin M. 1998. Quantitation of human immunodeficiency virus type 1 RNA in plasma by using blood dried on filter paper. J. Clin. Microbiol. 36:258-260.
31. Geng EH, Bwana MB, Kabakyenga J, Muyindike W, Emenyonu NI, Musinguzi N, Mugyenyi P, Martin JN, Bangsberg DR. 2010. Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda. PLoS One 5:e14098. doi: 10.1371/journal.pone.0014098.
32. Klausner JD, Serenata C, O'Bra H, Mattson CL, Brown JW, Wilson M, Mbengashe T, Goldman TM. 2011. Scale-up and continuation of antiretroviral therapy in South African treatment programs, 2005-2009. J. Acquir. Immune Defic. Syndr. 56:292-295.
33. Johannessen A, Garrido C, Zahonero N, Sandvik L, Naman E, Kivuyo SL, Kasubi MJ, Gundersen SG, Bruun JN, de Mendoza C. 2009. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania. Clin. Infect. Dis. 49:976-981.
34. Johannessen A, Troseid M, Calmy A. 2009. Dried blood spots can expand access to virological monitoring of HIV treatment in resourcelimited settings. J. Antimicrob. Chemother. 64:1126-1129.
35. Monleau M, Montavon C, Laurent C, Segondy M, Montes B, Delaporte E, Boillot F, Peeters M. 2009. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing. J. Clin. Microbiol. 47:1107-1118.
36. Steinmetzer K, Seidel T, Stallmach A, Ermantraut E. 2010. HIV load testing with small samples of whole blood. J. Clin. Microbiol. 48:2786-2792.
37. Do T, Duncan J, Butcher A, Liegler T. 2011. Comparative frequencies of HIV low-level viremia between real-time viral load assays at clinically relevant thresholds. J. Clin. Virol. 52(Suppl 1):S83-S89.
38. Manavi K. 2008. The significance of low-level plasma HIV viral load on COBAS TaqMan HIV-1 assays for patients with undetectable plasma viral load on COBAS Amplicor monitor version 1.5. HIV Clin. Trials 9:283-286.
39. Lima V, Harrigan R, Montaner JS. 2009. Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay. J. Acquir. Immune Defic. Syndr. 51:3-6.
40. Smit E, Bhattacharya S, Osman H, Taylor S. 2009. Increased frequency of HIV-1 viral load blip rate observed after switching from Roche Cobas Amplicor to Cobas Taqman assay. J. Acquir. Immune Defic. Syndr. 51: 364-365.
41. Panel on Antiretroviral Guidelines for Adults and Adolescents. 2011. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents Department of Health and Human Services, Rockville, MD. http://aidsinfo.nih.gov/guidelines. Accessed 26 October 2011.